GlassScriptPhysician profile
Scott L Darling
NPI 1376560714
$3,840.15
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2021: $88.16 · 2022: $2,438 · 2023: $205 · 2024: $287 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Titan Surgical Group, LLC | $2,996.77 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $150.00 | 2024 | Venclose Maven Catheter |
| Pfizer INC. | $134.03 | 2023 | |
| Medtronic, INC. | $88.16 | 2021 | |
| Journey Medical Corporation | $67.40 | 2025 | |
| Boston Scientific Corporation | $61.47 | 2024-2025 | Varithena Administration Pack |
| Amgen INC. | $47.85 | 2024-2025 | Otezla, Otezla |
| Biofrontera INC. | $36.57 | 2023-2024 | Xepi, Bf-Rhodoled, Ameluz |
| E.R. Squibb & Sons, L.L.C. | $31.25 | 2024 | Sotyktu |
| Kerecis Limited | $30.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lilly USA, LLC | $30.48 | 2023-2024 | Olumiant, Taltz |
| Samsung Hme America, INC. | $30.00 | 2019 | |
| Incyte Corporation | $27.48 | 2024 | Opzelura |
| Biocompatibles, INC. | $27.41 | 2019 | |
| Leo Pharma INC. | $21.19 | 2025 | Anzupgo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $20.45 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.63 | 2023 | Libtayo |
| Smith+Nephew, INC. | $19.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Darling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.